SGFG
BMY icon

Silver Grove Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Silver Grove Financial Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
2,491
+2,377
+2,085% +$136K 0.08% 185
2026
Q1 		$6.91K Buy
+114
New +$6.65K 0.01% 338

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Silver Grove Financial Group's BMY Position: Q2 2026 in Review

Silver Grove Financial Group increased its Bristol-Myers Squibb (BMY) stake by 2,085% in Q2 2026, buying an estimated $136K and bringing the position to 2,491 shares worth $144K. The position accounts for 0.08% of the portfolio, ranked #185.

Silver Grove Financial Group first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Silver Grove Financial Group held 2,491 shares of Bristol-Myers Squibb worth $144K as of Q2 2026.
  • Silver Grove Financial Group bought 2,377 Bristol-Myers Squibb shares in Q2 2026, an estimated $136K.
  • Bristol-Myers Squibb made up 0.08% of Silver Grove Financial Group's portfolio in Q2 2026, its #185 holding.
  • Silver Grove Financial Group first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
  • 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.